Form 8-K - Current report:
SEC Accession No. 0001566469-23-000067
Filing Date
2023-11-01
Accepted
2023-11-01 16:41:05
Documents
13
Period of Report
2023-10-26
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K nh-20231026.htm   iXBRL 8-K 26300
5 nh-20231026_g1.jpg GRAPHIC 19217
  Complete submission text file 0001566469-23-000067.txt   196799

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT nh-20231026.xsd EX-101.SCH 1892
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT nh-20231026_lab.xml EX-101.LAB 22877
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT nh-20231026_pre.xml EX-101.PRE 11981
7 EXTRACTED XBRL INSTANCE DOCUMENT nh-20231026_htm.xml XML 2588
Mailing Address 3000 RDU CENTER DRIVE SUITE 200 MORRISVILLE NC 27560
Business Address 3000 RDU CENTER DRIVE SUITE 200 MORRISVILLE NC 27560 8559496288
NantHealth, Inc. (Filer) CIK: 0001566469 (see all company filings)

EIN.: 273019889 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37792 | Film No.: 231368840
SIC: 7374 Services-Computer Processing & Data Preparation